Molecular evolution, species distribution, and clinical consequences of an endemic aminoglycoside resistance plasmid.
During the first 6 years after appearing in one hospital, a 92-kilobase conjugative plasmid, pBWH1, which encoded resistance to chloramphenicol and sulfonamides and determined TEM-1 beta-lactamase and 2''-aminoglycoside nucleotidyltransferase, underwent a variety of molecular changes. It was most prevalent initially in isolates of Klebsiella pneumoniae, then in isolates of Serratia marcescens, and finally, after nearly disappearing, in isolates of Enterobacter cloacae. Evolutionary changes in the plasmid did not account for its shifts in species distribution, since the original molecule was found in isolates of each species. The late resurgence of pBWH1 occurred after a copy of its original molecule entered a distinctive ornithine decarboxylase-negative strain of E. cloacae, new to the hospital. The resulting transconjugant strain, chromosomally resistant to topical silver salts and to cephalosporins, and with the addition of pBWH1-encoded aminoglycoside resistance, spread in the hospital by causing an outbreak of sepsis in the burn unit, where these were commonly used antibacterial agents. Thus, an endemic plasmid became prevalent in a new host species because one of its genes supplemented the fitness of an uncommon strain of the species for a particular clinical niche.
D000617:Aminoglycosides / Q000494:pharmacology*; D005075:Biological Evolution; D003428:Cross Infection; D004262:DNA Restriction Enzymes; D004269:DNA, Bacterial / Q000235:genetics; D004754:Enterobacter / Q000187:drug effects / Q000235:genetics*; D004755:Enterobacteriaceae / Q000235:genetics*; D007711:Klebsiella pneumoniae / Q000187:drug effects / Q000235:genetics*; D011815:R Factors; D012706:Serratia marcescens / Q000187:drug effects / Q000235:genetics*; D013045:Species Specificity; D013997:Time Factors
D000617:Aminoglycosides; D004269:DNA, Bacterial; D004262:DNA Restriction Enzymes